Diamidines for human African trypanosomiasis

被引:0
|
作者
Paine, Mary F. [2 ,3 ]
Wang, Michael Zhuo [2 ,3 ]
Generaux, Claudia N. [2 ,3 ]
Boykin, David W. [4 ]
Wilson, W. David [4 ]
De Koning, Harry P. [1 ]
Olson, Carol A. [5 ]
Pohlig, Gabriele [6 ,7 ]
Burri, Christian [6 ,7 ]
Brun, Reto [6 ,7 ]
Murilla, Grace A. [8 ]
Thuita, John K. [8 ]
Barrett, Michael P. [1 ]
Tidwell, Richard R. [2 ,3 ]
机构
[1] Univ Glasgow, Wellcome Trust Ctr Mol & Biochem Parasitol, Inst Infect Immun & Inflammat, Glasgow Biomed Res Ctr, Glasgow G12 8TA, Lanark, Scotland
[2] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA
[3] Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA
[4] Georgia State Univ, Dept Chem, Atlanta, GA 30302 USA
[5] Sapphire Oak Consultants, Lindenhurst, IL 60046 USA
[6] Swiss Trop & Publ Hlth Inst, Dept Pharmaceut Med, CH-4051 Basel, Switzerland
[7] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol, CH-4051 Basel, Switzerland
[8] Trypanosomiasis Res Ctr, Kenya Agr Res Inst, Kikuyu, Kenya
关键词
Blood-brain barrier; clinical trial; diamidine; drug metabolism; drug transport; furamidine; human African trypanosomiasis; pentamidine; sleeping sickness; SUBSTRATE RECOGNITION MOTIFS; ANTIPROTOZOAL ACTIVITY; PURINE TRANSPORTER; RNA-INTERFERENCE; PRODRUG DB289; AZA-ANALOGS; BRUCEI; PENTAMIDINE; RESISTANCE; AFFINITY;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aromatic diamidines are potent trypanocides. Pentamidine, a diamidine, has been used for more than 60 years to treat human African trypanosomiasis (HAT); however, the drug must be administered parenterally and is active against first-stage HAT only, prior to the parasites causing neurological deterioration through invasion of the CNS. A major research effort to design novel diamidines has led to the development of orally active prodrugs and, remarkably, a new generation of compounds that can penetrate the CNS. In this review, progress in the development of diamidines for the treatment of HAT is discussed.
引用
收藏
页码:876 / 883
页数:8
相关论文
共 50 条
  • [21] The Burden of Human African Trypanosomiasis
    Fevre, Eric M.
    v. Wissmann, Beatrix
    Welburn, Susan C.
    Lutumba, Pascal
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2008, 2 (12):
  • [22] Pharmacokinetic Comparison To Determine the Mechanisms Underlying the Differential Efficacies of Cationic Diamidines against First- and Second-Stage Human African Trypanosomiasis
    Yang, Sihyung
    Wenzler, Tanja
    Miller, Patrik N.
    Wu, Huali
    Boykin, David W.
    Brun, Reto
    Wang, Michael Zhuo
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (07) : 4064 - 4074
  • [23] Human African trypanosomiasis:: Epidemiology and control
    Fevre, E. M.
    Picozzi, K.
    Jannin, J.
    Welburn, S. C.
    Maudlin, I.
    [J]. ADVANCES IN PARASITOLOGY, VOL 61: CONTROL OF HUMAN PARASITIC DISEASES, 2006, 61 : 167 - +
  • [24] Treatment and control of human African trypanosomiasis
    Jannin, J
    Cattand, P
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2004, 17 (06) : 565 - 570
  • [25] The evolving spectrum of human African trypanosomiasis
    Kennedy, P. G. E.
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2023, 117 (06)
  • [26] RELATIONS BETWEEN PHARMACOKINETICS AND PROPHYLACTIC ACTION OF TRYPANOCIDAL DIAMIDINES IN TRYPANOSOMIASIS CONGOLENSE AND TRYPANOSOMIASIS BRUCEI
    FINK, E
    KALIWODA, G
    DANN, O
    [J]. TROPENMEDIZIN UND PARASITOLOGIE, 1977, 28 (02): : 272 - 272
  • [27] CARDIAC VALVULITIS IN HUMAN AFRICAN TRYPANOSOMIASIS
    POLTERA, AA
    COX, JN
    OWOR, R
    [J]. EAST AFRICAN MEDICAL JOURNAL, 1977, 54 (09) : 497 - 499
  • [28] Human African trypanosomiasis in travellers to Kenya
    Gobbi, F.
    Bisoffi, Z.
    [J]. EUROSURVEILLANCE, 2012, 17 (10): : 2 - 4
  • [29] New candidate for human African trypanosomiasis
    不详
    [J]. FUTURE MEDICINAL CHEMISTRY, 2011, 3 (10) : 1240 - 1240
  • [30] HEMIPLEGIC FORMS OF HUMAN AFRICAN TRYPANOSOMIASIS
    SONAN, T
    GIORDANO, C
    BOA, F
    DUMAS, M
    [J]. BULLETIN DE LA SOCIETE DE PATHOLOGIE EXOTIQUE, 1988, 81 (3BIS): : 459 - 463